Product Comparison


 
Merck 00006483703
Pfizer 00005197102
Merck 00006494300
Pfizer 00005197105
McKesson # 911398 795986 330568 842097
Description Pneumovax® 23 Pneumonia Vaccine Adults 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL Prevnar 13® Pneumonia Vaccine Children 6 Weeks Through 5 Years of Age and Adults 50 Years of Age and Older Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free Injection Prefilled Syringe 0.5 mL Pneumovax® 23 Pneumonia Vaccine Adults 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL Prevnar 13® Pneumonia Vaccine Children 6 Weeks Through 5 Years of Age and Adults 50 Years of Age and Older Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free Injection Prefilled Syringe 0.5 mL
Manufacturer # 00006483703000051971020000649430000005197105
Brand Pneumovax® 23Prevnar 13®Pneumovax® 23Prevnar 13®
Manufacturer MerckPfizerMerckPfizer
Invoice PNEUMOVAX, SYR 0.5ML (10/CT)PREVNAR 13, SYR 0.5ML (10/CT) 9WYETHPNEUMOVAX, SDV 25MCG/0.5ML 0.5ML (10/PK)PREVNAR 13, SYR 0.5ML
    Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 16146502021178
Container Type Prefilled SyringePrefilled SyringeSingle Dose VialPrefilled Syringe
Country of Origin United StatesUnknownUnited StatesUnknown
Generic Drug Code 43859282321428728232
Generic Drug Name Pneumococcal 23 Vaccine PolyvalentPneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative FreePneumococcal 23 Vaccine PolyvalentPneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free
NDC Number 00006-4837-0300005-1971-0200006-4943-0000005-1971-05
Strength 25 mcg / 0.5 mL25 mcg / 0.5 mL
Type Intramuscular or SubcutaneousIntramuscularIntramuscular or SubcutaneousIntramuscular
User Adults 50 Years of Age and OlderChildren 6 Weeks Through 5 Years of Age and Adults 50 Years of Age and OlderAdults 50 Years of Age and OlderChildren 6 Weeks Through 5 Years of Age and Adults 50 Years of Age and Older
Application Pneumonia VaccinePneumonia VaccinePneumonia VaccinePneumonia Vaccine
Dosage Form InjectionInjectionInjectionInjection
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
UNSPSC Code 51201615512016155120161551201615
Volume 0.5 mL0.5 mL0.5 mL0.5 mL
Features and Benefits
  • PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
  • PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
  • Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
  • Store unopened and opened vials at 2° - 8°C (36° - 46°F)
  • In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F
  • No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A
  • In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • The tip cap and rubber plunger of the prefilled syringe do not contain latex
  • Store Refrigerated at 2° to 8°C (36° to 46°F)
  • PNEUMOVAX 23 is supplied as a single-dose vial of liquid vaccine, in a box of 10 single dose vials, color coded with a purple cap and stripe on the vial labels and cartons
  • No dilution or reconstitution is necessary
  • PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged ≥2 years who are at increased risk for pneumococcal disease
  • In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F
  • No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A
  • In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • The tip cap and rubber plunger of the prefilled syringe do not contain latex
  • Store Refrigerated at 2° to 8°C (36° to 46°F)